Journal home
Advance online publication
Current issue
Archive
Press releases
Methagora
Focuses
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
naturejobs
For Advertisers
work@npg
naturereprints
About this site
For librarians
Application notes
 
NPG Resources
Nature
Nature Biotechnology
Nature Protocols
Nature Genetics
Nature Chemical Biology
Nature Cell Biology
Nature Neuroscience
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
Nature Reviews Drug Discovery
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Methods  2, 771 - 777 (2005)
Published online: 22 September 2005; | doi:10.1038/nmeth792

Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis

Petra Van Damme, Lennart Martens, Jozef Van Damme, Koen Hugelier, An Staes, Joël Vandekerckhove & Kris Gevaert

Department of Medical Protein Research, Flanders Interuniversity Institute for Biotechnology, Department of Biochemistry, Ghent University, A. Baertsoenkaai 3, B-9000 Ghent, Belgium.

Correspondence should be addressed to Kris Gevaert kris.gevaert@ugent.be

We generated a comprehensive picture of protease substrates in anti-Fas−treated apoptotic human Jurkat T lymphocytes. We used combined fractional diagonal chromatography (COFRADIC) sorting of protein amino-terminal peptides coupled to oxygen-16 or oxygen-18 differential labeling. We identified protease substrates and located the exact cleavage sites within processed proteins. Our analysis yielded 1,834 protein identifications and located 93 cleavage sites in 71 proteins. Indirect evidence of apoptosis-specific cleavage within 21 additional proteins increased the total number of processed proteins to 92. Most cleavages were at caspase consensus sites; however, other cleavage specificities suggest activation of other proteases. We validated several new processing events by immunodetection and by an in vitro assay using recombinant caspases and synthetic peptides containing presumed cleavage sites. The spliceosome complex appeared a preferred target, as 14 of its members were processed. Differential isotopic labeling further revealed specific release of nucleosomal components from apoptotic nuclei.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

ADVERTISEMENT

 
Nature Methods
ISSN: 1548-7091
EISSN: 1548-7105
Journal home | Current issue | Archive | Press releases |
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2005 Nature Publishing Group | Privacy policy